Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
63 Cards in this Set
- Front
- Back
what effects does insulin have on energy pathways
|
upregulate glycogenesis, inhibits lipolysis/ketogenesis
|
|
what causes acidosis in DMT1
|
no insulin to inhibit lipolysis/ketogenesis, so generates ketones from TAG, ketones are acidic
|
|
what is amyloid
|
protein aggregate deposits, secreted by beta cells, but aggregation makes them toxic to beta cells
|
|
describe effects of aging on beta cells
|
increased age leads to increase beta cell number/mass
|
|
what is the primary risk factor for DMT2
|
central obesity, which causes increased insulin resistance
|
|
define gestational diabetes
|
diabetes that is developed during pregnancy
|
|
complications of DMT2
|
increased BP, microvascular damage (retinopathy), accelerated vascular disease
|
|
describe pathway of triglyceride absorption
|
intestine package into chylomicrons and secrete into lymph > lipoprotein lipase (LPL) acts to hydrolyze to fatty acids > chylomicron remnants repackaged by liver to VLDL > LPL acts to make LDL > HDL
|
|
what process is use of triglycerides for energy
|
beta oxidation of FFA in mitochondria
|
|
what is the function of peroxisomes in beta oxidation
|
peroxisomes shorten very long chain fatty acids so they can enter mitochondria
|
|
what cholesterol-related parameters is dependent upon fasting
|
LDL = cholesterol -- HDL -- TAG/5
|
|
describe process of fatty acid release
|
fasting state > glucagon/epi > activates hormone sensitive lipase > hydrolysis of triglyercides
|
|
describe nitrogen balance
|
intake -- output; positive during growth; negative during injury
|
|
what are the types of amino acid classes
|
glucogenic, ketogenic, mixture of both
|
|
what is the function of PAH
|
conversion of phenylalanine to tyrosine
|
|
classic sign of PKU
|
mousy/musty odor
|
|
what is the pathogenesis of PKU
|
brain does not have PAH enzyme, high levels of Phe will prevent other amino acids from enter brain, leading to inability to synthesize proteins
|
|
what is the inheritance pattern of PKU
|
autosomal recessive
|
|
describe treatment process of PKU
|
screen as fetus > diet low in Phe (because Phe is essential amino acid) for life
|
|
what is maternal PKU
|
mother has PKU, must switch to low Phe diet before having fetus to prevent developmental disorders
|
|
classic sign of alkaptonuria
|
standing urine turns black
|
|
classic sign of maple syrup urine
|
sweet smelling urine
|
|
pathogenesis of maple syrup urine
|
accumulation of branched keto acids > CNS toxicity, acidosis
|
|
list three important cellular functions of lipids
|
1. apoptotic signaling molecule, phosphatidylserine; 2. cleave lipids to get signaling molecules, 3. surfactant
|
|
what is inheritance pattern of lysosomal storage diseases
|
mostly autosomal recessive
|
|
describe wolmans disease
|
defective cholesteral esterase, leads to accumulation of cholesterol esters and high blood cholesterol
|
|
describe pathogenesis of i-cell disease
|
enzymes cannot target lysosome, end up in bloodstream
|
|
what is the treatment for i-cell disease
|
give properly-formed enzymes, but will not pass through BBB
|
|
what is classic sign for tay-sachs
|
cherry-red spot in retina, or HEXA/HEXB screening
|
|
what is inheritance pattern of tay-sachs
|
autosomal recessive
|
|
describe pathogenesis of tay-sachs
|
defective HEXA > accumulation of lipids > neuronal cell death
|
|
what is inheritance pattern of hunter syndrome
|
x-linked recessive
|
|
pathogenesis of hunter syndrome
|
defective degradation of GAG
|
|
what are the limits of treating lysosome storage diseases by administering enzymes
|
enzymes cannot penetrate BBB
|
|
what is the sugar skeleton nucleotides are built on
|
regulation of PRPP synthesis from ribose sugar
|
|
describe synthesis of purines from PRPP
|
PRPP converted to IMP > precursor for GMP and AMP; to get dNTP form, must convert to GDP/ADP, then to dGDP/dADP
|
|
what are the regulatory mechanisms of purine synthesis
|
1. final products inhibit synthesis, 2. PRPP stimulates synthesis
|
|
how is dNTP synthesis inhibited
|
end products (dNTPs) inhibit enzyme that generates dNDPs from NDPs
|
|
what products are generated from purine degradation
|
uric acid and urate (insoluble)
|
|
interitance pattern of lesch-nyhan
|
x-linked recessive
|
|
pathogenesis of lesch-nyhan
|
inability to salvage purines shunts to degradation > elevated uric acid levels > gout
|
|
classic sign of lesch-nyhan
|
uric acid crystals are orange
|
|
symptoms of lesch-nyhan
|
self-mutiliation, neurological defects
|
|
what type of blood condition exacerbates gout
|
acidosis
|
|
pathogenesis of gout
|
overproduction of PRPP > excess purines > elevated uric acid > crystallizes/precipitates > gout
|
|
list typical symptoms of gout
|
1. hyperuricemia, 2. kidney urate precipitation, 3. arthritis (starts in big toe)
|
|
what is the treatment for gout
|
allopurinol, to inhibit purine degradation; or hydrate to prevent urate precipitation
|
|
what is pathogenesis of SCID
|
defective degradation of purines, leads to elevated dATPs > inhibits new synthesis of dATP > compromises immune system
|
|
signs or symptoms of SCID
|
recurrent infections, low WBC count
|
|
describe pyrimidine synthesis
|
orotate attached to PRPP > UMP > UTP > CTP
|
|
what is the significance of elevated carbamoyl phosphate
|
will stimulate UMP synthesis/degradation > elevated uracil
|
|
pathogenesis of hereditary orotic aciduria
|
defective enzyme for UMP synthesis causes elevated levels of orotic acid (intermediate) > anemia, retarded growth
|
|
treatment for hereditary orotic aciduria
|
give uridine > converted to UMP > will inhibit orotate synthesis and decrease orotate accumulation because have high levels of UMP already
|
|
describe the roux en-y surgery
|
stomach is shrunk and intestine is shortened and rerouted
|
|
what pathologies can be quickly resolved from bariatric surgery
|
diabetes, fatty liver
|
|
what is the hypothesis behind resolution of obesity-related problems
|
imbalance between interins and anti-interins
|
|
define c-reactive protein
|
inflammatory cytokine
|
|
two big risk factors for CV disease
|
1. elevated C-reactive protein, 2. elevated TC:HDL ratio: >4 high risk, <4 low risk
|
|
what is a mono-unsaturated fat
|
one double bond, rest of the chain is filled with hydrogen atoms
|
|
how are trans-fats created
|
commercialized homogenization process to convert unsaturated fat to saturated fat introduces trans-fat
|
|
what are the effects of trans-fats
|
1. lowers HDL, 2. increases CV risk
|
|
what is the primary effect of omega-3 fatty acid
|
lowers triglyceride levels
|
|
what are primary effects of conjugated linoleic acid
|
1. inhibits fat formation, 2. increases insulin sensitivity, 3. lowers cholesterol
|